BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21163929)

  • 1. Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors.
    Bretz J; Garcia J; Huang X; Kang L; Zhang Y; Toellner KM; Chen-Kiang S
    Blood; 2011 Feb; 117(7):2179-88. PubMed ID: 21163929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.
    Morse L; Chen D; Franklin D; Xiong Y; Chen-Kiang S
    Immunity; 1997 Jan; 6(1):47-56. PubMed ID: 9052836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-10 production in murine IgM
    Suzuki-Yamazaki N; Yanobu-Takanashi R; Okamura T; Takaki S
    Eur J Immunol; 2017 Mar; 47(3):493-503. PubMed ID: 28012163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference reveals a requirement for both p18INK4c and p27Kip1 in B lymphopoiesis.
    Wang YY; Li Z; Jiao D; Zhang Z; Shao X; Yuan J; Yu P
    J Mol Cell Biol; 2010 Aug; 2(4):209-16. PubMed ID: 20671115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
    Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
    Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.
    Potula HH; Xu Z; Zeumer L; Sang A; Croker BP; Morel L
    J Immunol; 2012 Sep; 189(6):2931-40. PubMed ID: 22896639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines.
    Eguchi T; Itadani H; Shimomura T; Kawanishi N; Hirai H; Kotani H
    Mol Cancer Ther; 2009 Jun; 8(6):1460-72. PubMed ID: 19509251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells.
    Tourigny MR; Ursini-Siegel J; Lee H; Toellner KM; Cunningham AF; Franklin DS; Ely S; Chen M; Qin XF; Xiong Y; MacLennan IC; Chen-Kiang S
    Immunity; 2002 Aug; 17(2):179-89. PubMed ID: 12196289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.
    Bai F; Pei XH; Pandolfi PP; Xiong Y
    Mol Cell Biol; 2006 Jun; 26(12):4564-76. PubMed ID: 16738322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization.
    Jourdan M; Caraux A; De Vos J; Fiol G; Larroque M; Cognot C; Bret C; Duperray C; Hose D; Klein B
    Blood; 2009 Dec; 114(25):5173-81. PubMed ID: 19846886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1.
    Huang X; Di Liberto M; Cunningham AF; Kang L; Cheng S; Ely S; Liou HC; Maclennan IC; Chen-Kiang S
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17789-94. PubMed ID: 15591344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early preplasma cells define a tolerance checkpoint for autoreactive B cells.
    Culton DA; O'Conner BP; Conway KL; Diz R; Rutan J; Vilen BJ; Clarke SH
    J Immunol; 2006 Jan; 176(2):790-802. PubMed ID: 16393962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
    Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.
    Klein U; Casola S; Cattoretti G; Shen Q; Lia M; Mo T; Ludwig T; Rajewsky K; Dalla-Favera R
    Nat Immunol; 2006 Jul; 7(7):773-82. PubMed ID: 16767092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL protein protects from C/EBP homologous protein (CHOP)-dependent apoptosis during plasma cell differentiation.
    Gaudette BT; Iwakoshi NN; Boise LH
    J Biol Chem; 2014 Aug; 289(34):23629-40. PubMed ID: 25023286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic induction of apoptosis by p53-inducible Bcl-2 family proteins Noxa and Puma.
    Nakajima W; Tanaka N
    J Nippon Med Sch; 2007 Apr; 74(2):148-57. PubMed ID: 17507791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2.
    Porstner M; Winkelmann R; Daum P; Schmid J; Pracht K; Côrte-Real J; Schreiber S; Haftmann C; Brandl A; Mashreghi MF; Gelse K; Hauke M; Wirries I; Zwick M; Roth E; Radbruch A; Wittmann J; Jäck HM
    Eur J Immunol; 2015 Apr; 45(4):1206-15. PubMed ID: 25678371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
    Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
    Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.